Mnangagwa gets Covid jab as Zimbabwe fights hesitancy
Zimbabwean President Emmerson Mnangagwa receives his first shot of the Chinese Sinovac Covid-19 vaccine on March 24, 2021.
Zimbabwean President Emmerson Mnangagwa has received his first shot of the Chinese Sinovac Covid-19 vaccine, even as the southern African country tries to encourage its people to get the jab.
President Mnangagwa got the jab on Wednesday in Victoria Falls, a tourism hub on the border with Zambia, where he also launched the second phase of the country’s Covid-19 immunisation drive.
The event was broadcast live on national television and was witnessed by leaders of various political parties.
“Let me reiterate the global call by the World Health Organisation that no one is safe until everyone is safe.
“I therefore challenge all of us in our respective communities to accept the vaccination programme and to shun vaccination hesitancy, misinformation and the negative conspiracy theories,” President Mnangagwa said.
“Getting vaccinated is a personal and family responsibility as well as a national obligation.”
Revive tourism
The Zimbabwean government says it wants to vaccinate the resort city’s entire population in the next 28 days so as to revive the tourism industry, which has been severely crippled by prolonged lockdowns, and to slow down the spread of the coronavirus.
Zimbabwe bought 200,000 doses of the Sinovac vaccine from China earlier this month. It has also received a donation of 400,000 doses of the Sinopharm vaccine, also from China.
The first phase of the country’s vaccination programme began on February 18 targeting frontline workers such as healthcare personnel, border officials and security forces.
Only 44 135 people had received their first jab as of March 23, leading to fears that Zimbabweans were reluctant to receive the Chinese vaccines.
Zimbabwe’s second phase of Covid-19 vaccination programme is targeting school teachers, the elderly, people with chronic illnesses, the elderly and religious leaders.
Approved vaccines
The vaccines that have so far been approved for use in Zimbabwe are the Sinopharm and Sinovac jabs from China, Russia’s Sputnik-V and India’s Covaxin, but only the Chinese vaccines have been delivered.
Zimbabwe aims to vaccinate 60 per cent of its population — or 10 million people — in an effort to achieve herd immunity and stop the uncontrolled spread of the coronavirus.
The country has started reopening its economy after new infections went down significantly following a deadly second wave of the outbreak of Covid-19 soon after the December festive season.
As of March 23, Zimbabwe had recorded 36,717 Covid-19 cases, 1,516 deaths and 34,447 recoveries.
